Biospecimen-Core
生物样本核心
基本信息
- 批准号:10385163
- 负责人:
- 金额:$ 27.57万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2021
- 资助国家:美国
- 起止时间:2021-09-30 至 2026-08-31
- 项目状态:未结题
- 来源:
- 关键词:
项目摘要
Project Summary
Senescent cells (SnCs) accumulate with age and in various chronic disease states and clearly contribute to
driving morbidity and mortality in model organisms. Drugs that selectively eliminate SnCs (“senolytics”) were first
developed by our team and have been demonstrated to reduce frailty, extend median lifespan, and attenuate
morbidity in murine models of numerous age-related diseases. However, SnCs also play a role in wound healing
and tissue remodeling. To advance senolytics to their greatest potential, then, it is imperative to understand more
about SnCs in humans with healthy aging. As part of SenNet, the proposed Minnesota Tissue Mapping Center
(MN TMC) has selected four tissues for identification, characterization, and spatio-temporal analysis of
senescence: adipose, skeletal muscle, liver, and ovarian tissues. These tissues were selected because of the
scientific expertise at UMN and Mayo Clinic in the biology of these organs, evidence of increased senescence
with age, and availability of biobanked specimens as well as surgical access to fresh tissues from healthy
individuals. The overall goal of the Biospecimen Core (BSP), co-directed by Dr. Sayeed Ikramuddin, Chair of
the UMN Department of Surgery, and Dr. Oyedele Adeyi, Professor of Laboratory Medicine and Pathology, is
to provide the tissues and blood for PBMC isolation to the Biological Analysis Core (BAC) for bulk, single cell,
and spatial analysis of human SnCs for subsequent multi-plex analysis of the results by the Data Analysis Core
(DAC). The BSP will leverage their strong track
record of obtaining high-quality, well-annotated human samples
from non-chronically diseased individuals who are metabolically characterized and with appropriate diversity in
gender, race, socio-economic status, ethnicity, and other relevant diversity parameters. The BSP will also
provide access to
UMN’s specimen procurement network (BioNet) that has ~70,000 archival tissues (frozen,
FFPE) and biofluids (frozen) collected for research, including several adipose depots, several muscles, liver from
organ donors, and healthy ovarian tissues removed because of benign lesions. In addition, the BSP has access
to tissues within the Rochester Epidemiology Project, which encompasses the medical records of all citizens
living in Olmsted County, MN since 1966, along with archived biological specimens. The Aims of the BSP are
to: 1) Prepare and maintain all regulatory materials supporting human tissue collection; 2) Recruit and consent
patients of different ages for this project; 3) Characterize the metabolic health of enrolled participants; 4)
Coordinate with BioNet for intraoperative specimen collection, annotation, and storage of tissues; 5) Procure and
annotate high quality target tissues along with relevant biofluids; 6) Longitudinally follow patients for which weight
loss and bariatric surgery are metabolic perturbations; 7) Disseminate the samples to MN TMC BAC; and 8)
Partner with SenNet to share tissues and to develop shared patient consent and tissue collection protocols with
appropriate Ethical, Legal and Social Implications and quality control and assurance considerations.
项目摘要
衰老细胞(SnC)随着年龄的增长和各种慢性疾病状态而积累,并明显有助于
导致模式生物的发病率和死亡率选择性消除SnCs的药物(“senolytics”)首先被用于治疗癌症。
由我们的团队开发,并已被证明可以减少虚弱,延长中位寿命,
许多年龄相关疾病的鼠模型中的发病率。然而,SnCs也在伤口愈合中发挥作用
和组织重塑。为了推进senolytics发挥其最大的潜力,那么,有必要了解更多
关于SnCs在人类健康衰老中的作用。作为SenNet的一部分,拟议的明尼苏达组织绘图中心
(MN TMC)选择了四种组织进行识别,表征和时空分析,
衰老:脂肪、骨骼肌、肝脏和卵巢组织。选择这些组织是因为
UMN和马约诊所在这些器官的生物学方面的科学专业知识,
随着年龄的增长,生物库标本的可用性以及手术获取健康人的新鲜组织,
个体生物样本核心(BSP)的总体目标,由主席Sayeed Ikramuddin博士共同指导,
UMN外科系和实验室医学和病理学教授Oyedele Adeyi博士是
向生物分析中心(BAC)提供用于PBMC分离的组织和血液,用于批量、单细胞,
人类SnCs的空间分析,用于数据分析核心对结果的后续多重分析
(发援会)。BSP将利用其强大的轨道
获得高质量、注释良好的人体样本的记录
来自非慢性疾病个体,这些个体具有代谢特征并且在以下方面具有适当的多样性:
性别、种族、社会经济地位、种族和其他相关多样性参数。BSP还将
提供访问
UMN的标本采购网络(BioNet)拥有约70,000个存档组织(冷冻,
FFPE)和收集用于研究的生物流体(冷冻),包括几个脂肪库、几块肌肉、来自
器官捐赠者和因良性病变而切除的健康卵巢组织。此外,BSP还可以访问
罗切斯特流行病学项目中的组织,该项目包括所有公民的医疗记录
自1966年起居住在明尼苏达州奥姆斯特德县,沿着的还有存档的生物标本。BSP的目标是
目的:1)准备和维护支持人体组织采集的所有监管材料; 2)招募和同意
本项目不同年龄段的患者; 3)描述入选参与者的代谢健康状况; 4)
与BioNet协调术中标本采集、注释和组织保存; 5)采集和
用相关的生物流体注释高质量的靶组织沿着; 6)纵向跟踪患者,
损失和减肥手术是代谢紊乱; 7)将样品传播到MN TMC BAC;和8)
与SenNet合作,共享组织,并制定共享的患者同意书和组织收集协议,
适当的道德、法律的和社会影响以及质量控制和保证考虑。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
SAYEED IKRAMUDDIN其他文献
SAYEED IKRAMUDDIN的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('SAYEED IKRAMUDDIN', 18)}}的其他基金
相似国自然基金
胆固醇羟化酶CH25H非酶活依赖性促进乙型肝炎病毒蛋白Core及Pre-core降解的分子机制研究
- 批准号:82371765
- 批准年份:2023
- 资助金额:50 万元
- 项目类别:面上项目
锕系元素5f-in-core的GTH赝势和基组的开发
- 批准号:22303037
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
基于合成致死策略搭建Core-matched前药共组装体克服肿瘤耐药的机制研究
- 批准号:
- 批准年份:2022
- 资助金额:52 万元
- 项目类别:
鼠伤寒沙门氏菌LPS core经由CD209/SphK1促进树突状细胞迁移加重炎症性肠病的机制研究
- 批准号:
- 批准年份:2022
- 资助金额:30 万元
- 项目类别:青年科学基金项目
基于外泌体精准调控的“核-壳”(core-shell)同步血管化骨组织工程策略的应用与机制探讨
- 批准号:
- 批准年份:2020
- 资助金额:55 万元
- 项目类别:
肌营养不良蛋白聚糖Core M3型甘露糖肽的精确制备及功能探索
- 批准号:92053110
- 批准年份:2020
- 资助金额:70.0 万元
- 项目类别:重大研究计划
Core-1-O型聚糖黏蛋白缺陷诱导胃炎发生并介导慢性胃炎向胃癌转化的分子机制研究
- 批准号:81902805
- 批准年份:2019
- 资助金额:20.5 万元
- 项目类别:青年科学基金项目
原始地球增生晚期的Core-merging大碰撞事件:地核增生、核幔平衡与核幔边界结构的新认识
- 批准号:41973063
- 批准年份:2019
- 资助金额:65.0 万元
- 项目类别:面上项目
CORDEX-CORE区域气候模拟与预估研讨会
- 批准号:41981240365
- 批准年份:2019
- 资助金额:1.5 万元
- 项目类别:国际(地区)合作与交流项目
RBM38通过协助Pol-ε结合、招募core调控HBV复制
- 批准号:31900138
- 批准年份:2019
- 资助金额:24.0 万元
- 项目类别:青年科学基金项目
相似海外基金
Core B: Biorepository and Biospecimen Resource Facility Core
核心 B:生物样本库和生物样本资源设施核心
- 批准号:
10630467 - 财政年份:2023
- 资助金额:
$ 27.57万 - 项目类别:
Core 2: Biospecimen, Metabolomics, and Pathology Core
核心 2:生物样本、代谢组学和病理学核心
- 批准号:
10711640 - 财政年份:2023
- 资助金额:
$ 27.57万 - 项目类别:
CORE 1: The Clinical Data and Biospecimen Repository Core
核心 1:临床数据和生物样本存储库核心
- 批准号:
10625688 - 财政年份:2023
- 资助金额:
$ 27.57万 - 项目类别:














{{item.name}}会员




